Previous Close | 11.19 |
Open | 11.60 |
Bid | 10.98 x 100 |
Ask | 11.14 x 100 |
Day's Range | 10.62 - 11.60 |
52 Week Range | 10.60 - 20.70 |
Volume | |
Avg. Volume | 597,165 |
Market Cap | 467.147M |
Beta (5Y Monthly) | 1.13 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.02 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 39.93 |
As you might know, UroGen Pharma Ltd. ( NASDAQ:URGN ) just kicked off its latest quarterly results with some very...
UroGen Pharma Ltd (URGN) reports a 21% increase in net product revenue and advances in drug development, while navigating financial and regulatory hurdles.